Yvonne Winhofer
Overview
Explore the profile of Yvonne Winhofer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
431
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bergenstal R, Asbjornsdottir B, Johanning Bari T, Hulkund S, Winhofer Y, Wysham C
Diabetes Technol Ther
. 2025 Mar;
PMID: 40040516
ONWARDS 9 explored, for the first time, the effect of continuous glucose monitoring (CGM)-based titration of once-weekly insulin icodec (icodec) on glycemic control and safety outcomes in individuals with type...
2.
Harreiter J, Just I, Weber M, Klepochova R, Bastian M, Winhofer Y, et al.
Obesity (Silver Spring)
. 2024 Nov;
32(12):2299-2309.
PMID: 39558211
Objective: The objective of this study was to identify sex differences in ntrahepatocellular (HCL) and intramyocardial lipids (MYCL) and cardiac function in participants with different grades of glucometabolic impairment and...
3.
Ferch M, Galli L, Fellinger P, Baumgartner-Parzer S, Sunder-Plassmann R, Krychtiuk K, et al.
Eur J Prev Cardiol
. 2024 Nov;
32(3):249-258.
PMID: 39535057
Aims: Familial hypercholesterolaemia (FH) is a severely underdiagnosed, inherited disease, causing dyslipidaemia and premature atherosclerotic cardiovascular disease. In order to facilitate screening in a broad clinical spectrum, we aimed to...
4.
Kietaibl A, Schutz-Fuhrmann I, Bozkurt L, Fruhwald L, Rami-Merhar B, Frohlich-Reiterer E, et al.
Wien Klin Wochenschr
. 2024 Aug;
136(Suppl 9):467-477.
PMID: 39196351
People living with diabetes mellitus can be supported in the daily management by diabetes technology with automated insulin delivery (AID) systems to reduce the risk of hypoglycemia and improve glycemic...
5.
Fellinger P, Beiglbock H, Semmler G, Pfleger L, Smajis S, Baumgartner C, et al.
J Clin Endocrinol Metab
. 2023 Apr;
108(10):e989-e997.
PMID: 37104943
Context: Non-alcoholic fatty liver disease (NAFLD) is a leading causes of liver-related morbidity and mortality. While data on acromegaly, a state of chronic growth hormone (GH)/insulin-like growth factor I (IGF-I)...
6.
Muschitz C, Kautzky-Willer A, Winhofer Y, Rauner M, Haschka J, Cejka D, et al.
Wien Klin Wochenschr
. 2023 Apr;
135(Suppl 1):207-224.
PMID: 37101043
Fragility fractures are increasingly recognized as a complication of both type 1 and type 2 diabetes, with fracture risk that increases with disease duration and poor glycemic control. The identification...
7.
Clodi M, Saely C, Hoppichler F, Resl M, Steinwender C, Stingl H, et al.
Wien Klin Wochenschr
. 2023 Apr;
135(Suppl 1):201-206.
PMID: 37101042
Diabetes mellitus, cardiovascular disease and heart failure are interacting dynamically. Patients being diagnosed with cardiovascular disease should be screened for diabetes mellitus. Enhanced cardiovascular risk stratification based on biomarkers, symptoms...
8.
Kautzky-Willer A, Winhofer Y, Weitgasser R, Lechleitner M, Harreiter J
Wien Klin Wochenschr
. 2023 Apr;
135(Suppl 1):129-136.
PMID: 37101033
In 1989 the St. Vincent Declaration aimed to achieve comparable pregnancy outcomes in women with diabetes and those with normal glucose tolerance. However, currently women with pre-gestational diabetes still feature...
9.
Kautzky-Willer A, Winhofer Y, Kiss H, Falcone V, Berger A, Lechleitner M, et al.
Wien Klin Wochenschr
. 2023 Apr;
135(Suppl 1):115-128.
PMID: 37101032
Gestational diabetes (GDM) is defined as any degree of glucose intolerance with onset during pregnancy and is associated with increased feto-maternal morbidity as well as long-term complications in mothers and...
10.
Lechleitner M, Kaser S, Hoppichler F, Roden M, Weitgasser R, Ludvik B, et al.
Wien Klin Wochenschr
. 2023 Apr;
135(Suppl 1):98-105.
PMID: 37101030
This guideline summarizes diagnosis of type 1 diabetes, including accompanying autoimmune disorders, insulin therapy regimens and glycemic target values.